wr 99210 has been researched along with phentolamine in 1 studies
| Studies (wr 99210) | Trials (wr 99210) | Recent Studies (post-2010) (wr 99210) | Studies (phentolamine) | Trials (phentolamine) | Recent Studies (post-2010) (phentolamine) |
|---|---|---|---|---|---|
| 59 | 0 | 12 | 9,141 | 270 | 265 |
| Protein | Taxonomy | wr 99210 (IC50) | phentolamine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.396 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.006 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 10 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.018 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.11 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0173 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.359 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.396 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0011 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0108 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.807 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.5495 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nettleton, MJ; Poyser, RH; Shorter, JH | 1 |
1 other study(ies) available for wr 99210 and phentolamine
| Article | Year |
|---|---|
The cardiovascular effects of two new triazine antimalarials, BRL 50216 (Clociguanil) and BRL 6231.
Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Antimalarials; Benzyl Compounds; Blood Pressure; Cardiac Output; Carotid Arteries; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Ethers; Femoral Artery; Femoral Vein; Heart Rate; Hemodynamics; Histamine; Isoproterenol; Nictitating Membrane; Norepinephrine; Phentolamine; Reserpine; Respiration; Triazines; Vagus Nerve; Vascular Resistance | 1974 |